Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 4,825.00
-115.00 (-2.33%)
Jun 10, 2026, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 112.22 billion as of June 10, 2026. Its market cap has decreased by -49.32% in one year.
Market Cap
112.22B
Enterprise Value
74.17B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,825.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 112.22B, a decrease of -29.97%. That is a compound annual growth rate of -6.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 114.89B | -50.55% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 188.42B |
| JETEMA, | 178.98B |
| Genexine | 129.16B |
| Macrogen | 124.57B |
| MedPacto | 114.65B |
| Amicogen | 92.65B |
| ENCell | 90.21B |
| GeneOne Life Science | 88.86B |